Evidence mapPaperPMID 39699070Full record

ReviewJournal of the International Society of Sports Nutrition2025

International society of sports nutrition position stand: β-hydroxy-β-methylbutyrate (HMB).

John A Rathmacher, Lisa M Pitchford, Jeffrey R Stout, Jeremy R Townsend, Ralf Jäger, Richard B Kreider, Bill I Campbell, Chad M Kerksick, Patrick S Harty, Darren G Candow and 4 more

Abstract readReview
In one paragraph

Review in Journal of the International Society of Sports Nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. [A study on effect of a novel total nutritional composition for repairing full-thickness skin defects in rats].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Prospect of Muscle-Building Supplement HMB in Alzheimer's Disease.Journal of clinical & experimental immunology · 2026
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

John A RathmacherMTI Biotech Inc, Ames, IA, USA.ORCID 0000-0002-8210-4289
Lisa M PitchfordMTI Biotech Inc, Ames, IA, USA.ORCID 0000-0002-6402-0823
Jeffrey R StoutUniversity of Central Florida, School of Kinesiology and Rehabilitation Sciences, Orlando, FL, USA.ORCID 0000-0001-6114-1649
Jeremy R TownsendResearch, Nutrition, and Innovation, AG1, Carson City, NV, USA.
Ralf JägerIncrenovo LLC, Whitefish Bay, WI, USA.ORCID 0000-0002-7345-9635
Richard B KreiderTexas A&M University, Exercise & Sports Nutrition Lab, Department of Kinesiology and Sports Management, College Station, TX, USA.ORCID 0000-0002-3906-1658
Bill I CampbellUniversity of South Florida, Performance & Physique Enhancement Laboratory, Exercise Science Program, Tampa, FL, USA.ORCID 0000-0002-4106-3871
Chad M KerksickLindenwood University, Exercise and Performance Nutrition Laboratory, College of Science, Technology, and Health, Saint Charles, MO, USA.ORCID 0000-0003-0458-7294
Patrick S HartyLindenwood University, Exercise and Performance Nutrition Laboratory, College of Science, Technology, and Health, Saint Charles, MO, USA.
Darren G CandowUniversity of Regina, Faculty of Kinesiology and Health Studies, Regina, SK, Canada.ORCID 0000-0002-6655-4482
Brandon M Roberts10 General Greene Ave, Military Performance Division, US Army Research Institute of Environmental Medicine, Natick, MA, USA.ORCID 0000-0003-0395-6967
Shawn M ArentUniversity of South Carolina, Department of Exercise Science, Arnold School of Public Health, Columbia, SC, USA.ORCID 0000-0003-0647-0591
Douglas S KalmanDr. Kiran C Patel College of Osteopathic Medicine, Nova Southeastern University, Nutrition Department, Davie, FL, USA.ORCID 0000-0003-0882-9748
Jose AntonioNova Southeastern University, Department of Health and Human Performance, Davie, FL, USA.ORCID 0000-0002-8930-1058

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Position Statement: The International Society of Sports Nutrition (ISSN) bases the following position stand on an analysis of the literature regarding the effects of β-Hydroxy-β-Methylbutyrate (HMB). The following 12 points have been approved by the Research Committee of the Society: 1. HMB is a metabolite of the amino acid leucine that is naturally produced in both humans and other animals. Two forms of HMB have been studied: Calcium HMB (HMB-Ca) and a free acid form of HMB (HMB-FA). HMB-FA appears to lead to increased appearance of HMB in the bloodstream when compared to HMB-Ca, though recent results are mixed. 2. The available safety/toxicity data suggest that chronic HMB-Ca and HMB-FA consumption are safe for oral HMB supplementation in humans up to at least one year. 3. There are no negative effects of HMB-Ca and HMB-FA on glucose tolerance and insulin sensitivity in humans. There may be improvements in glucose metabolism in younger adults. 4. The primary mode of action of HMB appears to be through its dual mechanism to enhance muscle protein synthesis and suppress muscle protein breakdown. HMB's activation of mTORC1 is independent of the leucine-sensing pathway (Sestrin2-GATOR2 complex). 5. HMB may help reduce muscle damage and promote muscle recovery, which can promote muscle growth/repair. HMB may also have anti-inflammatory effects, which could contribute to reducing muscle damage and soreness. 6. HMB consumption in close proximity to an exercise bout may be beneficial to increase muscle protein synthesis and attenuate the inflammatory response. HMB can provide a beneficial physiological effect when consumed both acutely and chronically in humans. 7. Daily HMB supplementation (38 mg/kg body weight) in combination with exercise training may improve body composition through increasing lean mass and/or decreasing fat mass with benefits in participants across age, sex, and training status. The most pronounced of these improvements in body composition with HMB have been observed in studies with robust resistance training programs and dietary control. 8. HMB may improve strength and power in untrained individuals, but its performance benefits in trained athletes are mixed and increase with an increase in study duration (>6 weeks). HMB's beneficial effects on athletic performance are thought to be driven by improved recovery. 9. HMB supplementation appears to potentially have a positive impact on aerobic performance, especially in trained athletes. The mechanisms of the effects are unknown. 10. HMB supplementation may be important in a non-exercising sedentary and aging population to improve muscle strength, functionality, and muscle quality. The effects of HMB supplementation with exercise are varied, but the combination may have a beneficial effect on the treatment of age-associated sarcopenia under select conditions. 11. HMB may be effective in countering muscle disuse atrophy during periods of inactivity due to illness or injury. The modulation of mitochondrial dynamics and lipid metabolism by HMB may be a potential mechanism for preventing disuse atrophy and aiding rehabilitation beyond HMB's effects on rates of muscle protein synthesis and degradation. 12. The efficacy of HMB in combination with certain nutrients may be enhanced under select conditions.

Indexed as

Dietary SupplementsSports Nutritional Physiological PhenomenaValeratesAthletic PerformanceHumansMuscle, SkeletalSports Nutritional Sciencesbeta-hydroxyisovaleric acidValeratesleucinesport nutritionsupplementationβ-Hydroxy-β-Methylbutyrate

Identifiers

PMID39699070
PMCPMC11740297

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.